Factor XII deficiency is strongly associated with primary recurrent abortions

Fertility and Sterility

Volumn 80, Issue 3, 2003, Pages 590-594

  Pauer, Hans Ulrich ^a,b   Burfeind, Peter ^b   Köstering, Heinz ^b   Emons, Günter ^b   Hinney, Bernd ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PLASMA FACTOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT ABORTION; RECURRENT DISEASE; REDUCTION; UNIVERSITY HOSPITAL;

EID: 0042336008     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00788-X     Document Type: Article

References (34)

1. Citarella F., Ravon D.M., Pascucci B., Felici A., Fantoni A., Hack C.E. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces. Eur J Biochem. 238:1996;240-249.
2. Coppola R., Cristilli P., Cugno M., Ariens R.A., Mari D., Mannucci P.M. Measurement of activated factor XII in health and disease. Blood Coagul Fibrinolysis. 7:1996;530-535.
3. Farsetti A., Misiti S., Citarella F., Felici A., Andreoli M., Fantoni A., et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology. 136:1995;5076-5083.
4. Mahdi F., Madar Z.S., Figueroa C.D., Schmaier A.H. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood. 99:2002;3585-3596.
5. Zeerleder S., Schloesser M., Redondo M., Wuillemin W.A., Engel W., Furlan M., et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families. Thromb Haemost. 82:1999;1240-1246.
6. Colhoun H.M., Zito F., Norman Chan N., Rubens M.B., Fuller J.H., Humphries S.E. Activated factor XII levels and factor XII 46C >T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects. Atherosclerosis. 163:2002;363-369.
7. Girolami A., Simioni P., Scarano L., Girolami B., Zerbinati P. Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. J Thromb Thrombolysis. 9:2000;271-275.
8. Halbmayer W.M., Mannhalter C., Feichtinger C., Rubi K., Fischer M. [Factor XII (Hageman factor) deficiency a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction] . Wien Med Wochenschr. 143:1993;43-50.
9. Schloesser M., Zeerleder S., Lutze G., Halbmayer W.M., Hofferbert S., Hinney B., et al. Mutations in the human factor XII gene. Blood. 90:1997;3967-3977.
10. Saade G.R., McLintock C. Inherited thrombophilia and stillbirth. Semin Perinatol. 26:2002;51-69.
11. Sarig G., Younis J.S., Hoffman R., Lanir N., Blumenfeld Z., Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 77:2002;342-347.
12. Gris J.C., Ripart-Neveu S., Maugard C., Tailland M.L., Brun S., Courtieu C., et al. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost. 77:1997;1096-1103.
13. Braulke I., Pruggmayer M., Melloh P., Hinney B., Kostering H., Gunther E. Factor XII (Hageman) deficiency in women with habitual abortion new subpopulation of recurrent aborters? Fertil Steril. 59:1993;98-101.
14. Matsuura T., Kobayashi T., Asahina T., Kanayama N., Terao T. Is factor XII deficiency related to recurrent miscarriage? Semin Thromb Hemost. 27:2001;115-120.
15. Yamada H., Kato E.H., Ebina Y., Kishida T., Hoshi N., Kobashi G., et al. Factor XII deficiency in women with recurrent miscarriage. Gynecol Obstet Invest. 49:2000;80-83.
16. Yamada H., Kato E.H., Kobashi G., Ebina Y., Shimada S., Morikawa M., et al. Recurrent pregnancy loss etiology of thrombophilia . Semin Thromb Hemost. 27:2001;121-129.
17. Jones D.W., Gallimore M.J., Harris S.L., Winter M. Antibodies to factor XII associated with lupus anticoagulant. Thromb Haemost. 81:1999;387-390.
18. Lee R.M., Silver R.M. Recurrent pregnancy loss summary and clinical recommendations . Semin Reprod Med. 18:2000;433-440.
19. Rai R., Regan L. Thrombophilia and adverse pregnancy outcome. Semin Reprod Med. 18:2000;369-377.
20. Sanson B.J., Friederich P.W., Simioni P., Zanardi S., Hilsman M.V., Girolami A., et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost. 75:1996;387-388.
21. Franco R.F., Reitsma P.H. Genetic risk factors of venous thrombosis. Hum Genet. 109:2001;369-384.
22. Halbmayer W.M., Haushofer A., Schon R., Mannhalter C., Strohmer E., Baumgarten K., et al. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population evaluation of the incidence of FXII deficiency among 300 healthy blood donors . Thromb Haemost. 71:1994;68-72.
23. Ogasawara M.S., Aoki K., Katano K., Ozaki Y., Suzumori K. Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril. 75:2001;916-919.
24. Iinuma Y., Sugiura-Ogasawara M., Makino A., Ozaki Y., Suzumori N., Suzumori K. Coagulation factor XII activity, but not an associated common genetic polymorphism (46C/T), is linked to recurrent miscarriage. Fertil Steril. 77:2002;353-356.
25. Kohler H.P., Carter A.M., Stickland M.H., Grant P.J. Levels of activated FXII in survivors of myocardial infarction - association with circulating risk factors and extent of coronary artery disease. Thromb Haemost. 79:1998;14-18.
26. Furie B., Furie B.C. The molecular basis of blood coagulation. Cell. 53:1988;505-518.
27. Braat E.A., Dooijewaard G., Rijken D.C. Fibrinolytic properties of activated FXII. Eur J Biochem. 263:1999;904-911.
28. Dizon-Townson D.S., Meline L., Nelson L.M., Varner M., Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol. 177:1997;402-405.
29. Ong K., Horsfall W., Conway E.M., Schuh A.C. Early embryonic expression of murine coagulation system components. Thromb Haemost. 84:2000;1023-1030.
30. Rai R., Regan L. Obstetric complications of antiphospholipid antibodies. Curr Opin Obstet Gynecol. 9:1997;387-390.
31. Rai R.S., Regan L., Chitolie A., Donald J.G., Cohen H. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol. 103:1996;842-844.
32. Cui J., Eitzman D.T., Westrick R.J., Christie P.D., Xu Z.J., Yang A.Y., et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 96:2000;4222-4226.
33. Eitzman D.T., Westrick R.J., Bi X., Manning S.L., Wilkinson J.E., Broze G.J., et al. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation. 105:2002;2139-2142.
34. Soria J.M., Almasy L., Souto J.C., Bacq D., Buil A., Faure A., et al. A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet. 70:2002;567-574.